BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28435934)

  • 1. The Amblyopia Treatment Studies: Implications for Clinical Practice.
    Chen AM; Cotter SA
    Adv Ophthalmol Optom; 2016 Aug; 1(1):287-305. PubMed ID: 28435934
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized trial of treatment of amblyopia in children aged 7 to 17 years.
    Scheiman MM; Hertle RW; Beck RW; Edwards AR; Birch E; Cotter SA; Crouch ER; Cruz OA; Davitt BV; Donahue S; Holmes JM; Lyon DW; Repka MX; Sala NA; Silbert DI; Suh DW; Tamkins SM;
    Arch Ophthalmol; 2005 Apr; 123(4):437-47. PubMed ID: 15824215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Combined Occlusion and Atropine Therapy" Versus "Augmented Part-Time Patching" in Children with Refractory/Residual Amblyopia: A Pilot Study.
    Sachdeva V; Mittal V; Gupta V; Gunturu R; Kekunnaya R; Chandrasekharan A; Chabblani PP; Rao HL
    Middle East Afr J Ophthalmol; 2016; 23(2):201-7. PubMed ID: 27162453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial.
    Repka MX; Kraker RT; Holmes JM; Summers AI; Glaser SR; Barnhardt CN; Tien DR;
    JAMA Ophthalmol; 2014 Jul; 132(7):799-805. PubMed ID: 24789375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children.
    Repka MX; Wallace DK; Beck RW; Kraker RT; Birch EE; Cotter SA; Donahue S; Everett DF; Hertle RW; Holmes JM; Quinn GE; Scheiman MM; Weakley DR;
    Arch Ophthalmol; 2005 Feb; 123(2):149-57. PubMed ID: 15710809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of amblyopia: current practice and emerging trends.
    Papageorgiou E; Asproudis I; Maconachie G; Tsironi EE; Gottlob I
    Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1061-1078. PubMed ID: 30706134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years.
    ; Repka MX; Kraker RT; Beck RW; Holmes JM; Cotter SA; Birch EE; Astle WF; Chandler DL; Felius J; Arnold RW; Tien DR; Glaser SR
    Arch Ophthalmol; 2008 Aug; 126(8):1039-44. PubMed ID: 18695096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children.
    Pediatric Eye Disease Investigator Group.
    Arch Ophthalmol; 2002 Mar; 120(3):268-78. PubMed ID: 11879129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial.
    Scheiman MM; Hertle RW; Kraker RT; Beck RW; Birch EE; Felius J; Holmes JM; Kundart J; Morrison DG; Repka MX; Tamkins SM;
    Arch Ophthalmol; 2008 Dec; 126(12):1634-42. PubMed ID: 19064841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric eye disease investigator group amblyopia treatment review.
    Rees MG; Woo CL; Optom B
    Am Orthopt J; 2007; 57():99-103. PubMed ID: 21149162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years.
    Tailor V; Ludden S; Bossi M; Bunce C; Greenwood JA; Dahlmann-Noor A
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD011347. PubMed ID: 35129211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Could binocular treatment be a substitute for patching].
    Shi XF; Zhao KX
    Zhonghua Yan Ke Za Zhi; 2017 Dec; 53(12):885-889. PubMed ID: 29325380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical translation of recommendations from randomized clinical trials on patching regimen for amblyopia.
    Jin YP; Chow AH; Colpa L; Wong AM
    Ophthalmology; 2013 Apr; 120(4):657-62. PubMed ID: 23395531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Influencing the Success of Atropine Penalization Treatment in Amblyopia Patients Non-Responsive to Occlusion Treatment.
    Sultan P; Demir U; Sonmezay SE; Gungel H
    J Binocul Vis Ocul Motil; 2022; 72(4):212-218. PubMed ID: 36067468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors.
    Pediatric Eye Disease Investigator Group
    Ophthalmology; 2003 Aug; 110(8):1632-7; discussion 1637-8. PubMed ID: 12917184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical research in pediatric ophthalmology: the Pediatric Eye Disease Investigator Group.
    Beck RW
    Curr Opin Ophthalmol; 2002 Oct; 13(5):337-40. PubMed ID: 12218466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance and patching and atropine amblyopia treatments.
    Wang J
    Vision Res; 2015 Sep; 114():31-40. PubMed ID: 25743080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial of patching versus atropine penalization for the treatment of anisometropic amblyopia in older children.
    Menon V; Shailesh G; Sharma P; Saxena R
    J AAPOS; 2008 Oct; 12(5):493-7. PubMed ID: 18534880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Combined Atropine and Patching vs Patching Alone for Treatment of Severe Amblyopia in Children Aged 3 to 12 Years: A Randomized Clinical Trial.
    Wang S; Wen W; Zhu W; Liu Y; Zou L; Tian T; Lin J; Liu R; Liu H
    JAMA Ophthalmol; 2021 Sep; 139(9):990-996. PubMed ID: 34264296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amblyopia treatment: 1998 versus 2004.
    Khazaeni L; Quinn GE; Davidson SL; Forbes BJ
    J Pediatr Ophthalmol Strabismus; 2009; 46(1):19-22; quiz 23-4. PubMed ID: 19213272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.